Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), presented clinical data at the...
Diadem SpA announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for Alzheimer's disease (AD). The...
